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The impact of herbicide tolerant crops on non-target 
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Tolerance to broad spectrum herbicides is the most worldwide 
cultivated transgenic trait and millions of hectares have been 
sown with herbicide tolerant (HT) soybeans, maize, and 
canola. Among potential effects of this kind of genetically 
modified (GM) crops on the environment are those on non-
target organisms (NTOs). A NTO is any species that is not the 
direct target of the GM crop and may include non-target plants 
(particularly in the margins and nearby habitats), plant 
pathogens, arthropods birds and wildlife, and a diversity of soil 
organisms.  The impact of HT crops on non-target organisms 
may be exerted through three main mechanisms: (i) the direct 
effect of the trait introduced into the plant on the NTO, (ii) the 
effect of the herbicide on the NTO, and (iii) through the food 
web.  While there are no records in the literature of any effect 
through the first mechanism to our knowledge, and relatively 
very few through the second one, more effects have been 
described through trophic relationships mainly originated by 
the alteration of the abundance, composition and phenology of 
weed flora. This presentation is mainly focused on this third 
mechanism and particularly on weed- arthropods relationships 
as the first trophic interaction that leads to build complex food 
webs in agroecosystems.  According to the experience of 
Spanish field trials with HT maize, few changes in NTO 
populations may be expected if modifications of weed flora are 
not dramatic. Potential benefits derived from the flexibility of 
timing broad spectrum herbicide sprayings are discussed. 
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It is widely recognized in the scientific community that 
genetically engineered crops are safe for human consumption. 
Yet serious concerns continue about the safety of these foods, 
despite consumption of approximately two trillion meals by 
people over the past decade with no known ill effects. During 
2013, for example, new laws were proposed in California and 
Washington State to label foods containing genetically 
modified organisms (GMOs), the rationale being that people 
have a right to know what they eat. Although both laws failed, 
there is little doubt the public remains concerned about GMO 
food safety. Unknown to the public and many scientists is that 
Bacillus thuringiensis (Bt), the source of the insecticidal 
proteins used in insect-tolerant crops such as Bt corn and Bt 
soybeans, occurs naturally and commonly on many 
vegetables, grains, and nuts, including products based on 
these such as flour and flour products (bread, pasta), cereals, 
soup, salami, candy and puddings. Moreover, and ironically, 
 
 
the only insecticides permitted for use on organic crops are 
Bts that contain viable spores and the same Cry proteins used 
in GMO crops. Whether due to natural occurrence or the use 
of Bt insecticides, these foods can contain hundreds to 
thousands of viable spore/crystal mixtures per gram or cm
2
. In 
this presentation, I will review the data showing that Bt occurs 
naturally and commonly in our food supply, and that the 
diversity of strains and insecticidal proteins which people 
consume is much greater than those used in commercial Bt 
insecticides or GMO crops. 
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Before genetically engineered (GE) crops can be grown 
commercially, potential risks to the environment need to be 
assessed. Environmental risk assessment (ERA) ensures that 
desired ecological functions (protection goals), such as 
biological control, pollination, and decomposition are not 
harmed. We will present the process of non-target ERA for GE 
plants producing insecticidal proteins derived from Bacillus 
thuringiensis (Bt). Spiders are among the most abundant 
biological control agents in arable systems and we will use 
examples from our research to illustrate the different ERA 
steps. 
The populations of species associated to the ecosystem 
services to be protected represent assessment endpoints for 
the ERA. Knowledge on the community inhabiting the GE crop 
grown in a certain region (receiving environment) is combined 
with knowledge on potential exposure and sensitivity to the 
insecticidal compound to focus the assessment and to 
formulate relevant risk hypothesis to be tested. The different 
risk hypotheses are then addressed in the analysis phase of 
the ERA following a tiered approach. Early-tier testing is 
conducted under worst-case exposure conditions in the 
laboratory. Surrogate test species are selected that are most 
likely to reveal an adverse effect. More complex and realistic 
semi-field or field studies supplement the ERA when 
uncertainty about the level of risk to non-target species 
remains high after early tier laboratory studies are conducted. 
We will discuss important criteria to consider when designing 
non-target studies, which can only inform the ERA if they are 
reproducible, reliable, and test clearly defined risk hypotheses. 
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Publicly funded research into the environmental risks of 
genetically modified plants has been performed in Germany for 
more than a decade. The Bt-maize events MON810, 
MON88017 and MON89034 x MON88017 were assessed in 
field trials. Each of the trials lasted for 3 years and lead to the 
further refinement of trial designs and assessment methods. 
The combined results on non-target organism effects show that 
a) the assessed Bt-maize events do not harm the communities 
of NTOs typical for maize; b) conventional treatments with 
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insecticides can have profound negative impacts; c) 
conventionally bred maize varieties can differ substantially in 
their impact; d) different management practices have profound 
impacts on populations on-crop and off-crop. A number of 
conclusion can be drawn from the assessments: 1. The NTO 
ERA for Bt-maize should more strongly rely on early tier 
experiments; 2. Field trials are only sensible if results from 
earlier tiers show the possibility for negative NTO impacts; 3. A 
comparative approach to ERA is without alternative, also 
looking at conventionally bred varieties and alternative 
management approaches; 4. The methods and trial designs 
used are able to detect differences in impact of different maize 
varieties; 5. To fully assess the potential impacts of the 
cultivation of Bt- and other genetically modified plants a 
systems approach is needed, that also takes into account the 
benefits of using these plants; 6. A decision is needed on what 
we really want to protect and thus need to assess. 
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Beginning in about 2009, a new, emerging disease called 
“Early Mortality Syndrome or EMS” (more descriptively called 
Acute Hepatopancreas Necrosis Syndrome or AHPNS) began 
to cause significant production losses in shrimp farms 
southern China.  By 2010 the range of affected farms in China 
had expanded, and by 2011 EMS/AHPNS was confirmed in 
Vietnam and Malaysia, and in Thailand in 2012.  EMS/AHPNS 
disease has caused serious losses in the areas affected by 
the disease, and it has also caused secondary impacts on 
employment, social welfare, and international market 
presence. EMS/AHPNS was first classified as an idiopathic 
disease because no causative agent had been identified. 
Preliminary studies conducted in Vietnam in 2012 by the 
Laboratory of Aquaculture Pathology at the University of 
Arizona (UAZ-APL) have indicated that EMS/AHPNS is 
infectious. Since early in 2013, the UAZ-APL was able to 
isolate and identify the causative agent of EMS/AHPNS in 
pure culture. In several separate challenge experiments, the 
same EMS/AHPNS pathology was reproduced consistently in 
experimental shrimp.  In addition, the same identical agent 
was recovered from the challenged animals and several 
subsequence challenge tests using the recovered agent could 
also reproduce EMS/AHPNS pathology with very consistent 
results. The agent was identified as a unique strain of Vibrio 
 
parahaemolyticus that is commonly found in marine 
environment. Hence, EMS/AHPNS has a bacterial causative 
agent that satisfies Koch’s Postulates to be a typical infectious 
disease. Further studies focusing on the agent of AHPNS 
revealed that the agent could produce toxin(s) causing the 
primary pathology in affected shrimp. 
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Animal diseases gain political attention by their inclusion on 
lists of global bodies such as those of the World Organisation 
for Animal Health. Currently, the OIE lists 116 diseases 
caused by viral, bacterial, fungal, protistan, and metazoan 
pathogens. Each is afforded a specific chapter in the regularly 
updated OIE ‘Manual of Diagnostic Tests’ series. Of these, 30 
diseases are caused by eukaryotic (fungal, oomycete, 
protistan, and metazoan) parasites. Inclusion necessitates 
national governments to report outbreaks promptly but may 
lead to trading restrictions between nations in an attempt to 
limit spread. Detection therefore has consequences that may 
directly impact from farm to state levels. Here, we consider 
current approaches to discrimination of listed parasites from 
related, but unlisted, counterparts. We outline problems with 
defining ‘species’, propose the necessary drivers that should 
be required for discrimination of important taxa, and highlight 
how this process may be influenced by national policies. 
Further, we propose a set of ‘best practice’ measures, broadly 
based upon current taxonomic philosophies for protists and 
metazoans that should be applied when defining taxa for 
listing as notifiable. We will illustrate these principles with 
topical issues associated with the taxonomy and listing of 
aquatic invertebrate pathogens.  
 
   
Symposium. Thursday, 9:00. 205  
The Next Generation of Crustacean Health: Disease 
Diagnostics Using Modern Transcriptomics 
K. Fraser Clark 
1,2,3
; Spencer J. Greenwood 
1,2
; 
1
 Atlantic Veterinary College Lobster Science Centre; 
2
 
Department of Biomedical Sciences, University of Prince 
Edward Island, Charlottetown, Prince Edward Island, Canada; 
3
 Department of Plant and Animal Sciences, Dalhousie 
University, Truro, Nova Scotia, Canada 
Address for correspondence: fclark@upei.ca 
 
Commercial crustacean fisheries on the Atlantic coast of 
Canada represent over $(CAD) 1 billion annually. The 
American lobster (Homarus americanus) fishery alone 
represents over $(CAD) 600 million with harvests in recent 
years breaking records for amount of lobster that has been 
landed. The Canadian and Maine USA lobster populations 
remain healthy but the once vibrant lobster fisheries in 
Southern New England USA have been devastated by a 
mixture of disease, ocean acidification, global warming and 
anthropogenic stressors. Conventional gross anatomic, 
microscopic and histological analysis remain the backbone of 
 
